DOCSLIB.ORG
Explore
Sign Up
Log In
Upload
Search
Home
» Tags
» Ciglitazone
Ciglitazone
Stimulatory Action of Telmisartan, an Antagonist of Angiotensin II Receptor, on Voltage-Gated Na+ Current: Experimental and Theoretical Studies
REVIEW Peroxisome Proliferator-Activated Receptors In
PHARMACEUTICAL APPENDIX to the TARIFF SCHEDULE 2 Table 1
Pharmaceuticals Appendix
Open Full Page
New Mechanism-Based Anticancer Drugs That Act As Orphan
The Use of Immortalized Hepatocytes in Induction Studies
Pharmaceutical Appendix to the Harmonized Tariff Schedule
Design, Synthesis, and Evaluation of Thiazolidinedione Derivatives Inhibiting Bcl-2/Bcl-Xl Or Ablating Androgen Receptor for the Treatment of Prostate Cancer
Medical Treatments for Endometriosis-Associated Pelvic Pain
Ciglitazone—A Human Pparγ Agonist—Disrupts Dorsoventral Patterning in Zebrafish
(12) United States Patent (10) Patent No.: US 8,383,154 B2 Bar-Shalom Et Al
Stembook 2018.Pdf
Induced Liver Injury
Safety of Drug Use in Patients with a Primary Mitochondrial Disease: an International Delphi-Based Consensus
The Peroxisome Proliferator-Activated Receptor in Ovarian Biology Nicole Shivonn Tinfo Iowa State University
(12) United States Patent (10) Patent No.: US 8,865,213 B2 Sheth Et Al
(12) Patent Application Publication (10) Pub. No.: US 2004/0058896 A1 Dietrich Et Al
Top View
Track 6 Cardiovascular System and Obesity P152 P153 P154 P155
Studies on the Role of Peroxisome Proliferators: in Liver Growth and Neurodegenerative Disorders
Identification of Novel HBV/HDV Entry Inhibitors by Pharmacophore
Predicting Drug Responses by Propagating Interactions Through Text-Enhanced Drug-Gene Networks
Antiproliferative and Apoptotic Effects of Telmisartan in Human Colon Cancer Cells
Ciglitazone, a Peroxisome Proliferator-Activated Receptor Gamma Ligand, Inhibits Proliferation and Differentiation of Th17 Cells
Chemical Structure-Related Drug-Like Criteria of Global Approved Drugs
(PPAR) Agonists in Substance Use Disorders: a Synthesis of Preclinical and Human Evidence
Nifedipine Prevents Hepatic Fibrosis in a Non-Alcoholic Steatohepatitis Model Induced by an L-Methionine-And Choline-Deficient Diet
(12) Patent Application Publication (10) Pub. No.: US 2016/00384.11 A1 Cowles Et Al
(12) Patent Application Publication (10) Pub. No.: US 2006/027581.6 A1 Henderson Et Al
Ciglitazone Negatively Regulates CXCL1 Signaling Through MITF to Suppress Melanoma Growth
Independent Mechanisms Γ Lymphoma Apoptosis by PPAR
Tarif Intégré Des Communautés Européennes (TARIC)
INFLAMMATORY BOWEL DISEASE MONITOR Commentary and Analysis on Advances in the Understanding and Management of Inflammatory Bowel Disease
Thiazolidenediones Mediate Apoptosis in Prostate Cancer Cells in Part Through Inhibition of Bcl-Xl/Bcl-2 Functions Independently of PPAR;
The Role of the Sodium-Taurocholate Cotransporting Polypeptide (NTCP) and of the Bile Salt Export Pump (BSEP) in Physiology and Pathophysiology of Bile Formation
Combined Bezafibrate and Medroxyprogesterone Acetate: Potential Novel Therapy for Acute Myeloid Leukaemia
Oral Presentations 01 Medulloblastoma/Cns-Pnet—Biology
UNIVERSITY of CALIFORNIA RIVERSIDE Disruption of Nuclear
Supplementary Information for Drug Metabolism and Disposition
Telmisartan, an Angiotensin II Receptor Blocker, Attenuates Prevotella
Harmonized Tariff Schedule of the United States (2006) (Rev
The Use of Stems in the Selection of International Nonproprietary Names (INN) for Pharmaceutical Substances
Ep 1253910 B1
Troglitazone Improves Psoriasis and Normalizes Models of Proliferative
PPAR Agonists
Pharmaceutical Appendix to the Harmonized Tariff Schedule
Pleiotropic Effects of Glitazones: a Double Edge Sword?
Customs Tariff - Schedule
Pharmaceutical Appendix to the Tariff Schedule 2
The Use of Stems in the Selection of International Nonproprietary Names (INN) for Pharmaceutical Substances
Biomol ICCB Known Bi#123261
Peroxisome Proliferator-Activated Receptor-Gamma Agonists Inhibit
Ppars and Myocardial Infarction
PPAR) Gamma Agonists and Antagonists
WO 2009/055925 Al
Cinnamic Acid Based Thiazolidinediones Inhibit Human P450c17 and 3-Hydroxysteroid Dehydrogenase and Improve Insulin Sensitivity Independent of PPAR Agonist Activity
Towards Predicting Drug-Induced Liver Injury (DILI): Parallel
Learningpharmacology 2018.Pdf
Schedule Clxxiii - European Union
The Journey of Thiazolidinediones As Modulators of Ppars for the Management of Diabetes: a Critical Review
The Use of Immortalized Hepatocytes in Induction Studies